Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 4/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 4/20 | 0.42 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 4/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26528511 | 0.92 | ALDH1A1 (0.41) | RXFP1MAPTKMT2APOLBALDH1A1 | |
| SCHEMBL23474814 | 0.83 | MEN1 (0.30) | MAPTKMT2AMEN1 | |
| SCHEMBL23474663 | 0.81 | ALDH1A1 (0.46) | RXFP1MAPTKMT2APOLBALDH1A1 | |
| SCHEMBL18667528 | 0.79 | ALDH1A1 (0.48) | MAPTKMT2APOLBALDH1A1KDM4E | |
| SCHEMBL19161712 | 0.79 | ALDH1A1 (0.41) | RXFP1MAPTKMT2APOLBALDH1A1 | |
| SCHEMBL19162376 | 0.79 | ALDH1A1 (0.41) | RXFP1MAPTKMT2APOLBALDH1A1 | |
| SCHEMBL19161319 | 0.78 | ALDH1A1 (0.41) | MAPTKMT2APOLBALDH1A1KDM4E | |
| SCHEMBL19162304 | 0.78 | ALDH1A1 (0.42) | MAPTKMT2APOLBALDH1A1KDM4E | |
| SCHEMBL19161637 | 0.78 | ALDH1A1 (0.41) | RXFP1MAPTKMT2APOLBALDH1A1 | |
| SCHEMBL21449176 | 0.78 | ALDH1A1 (0.41) | RXFP1MAPTKMT2APOLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11787789-B2 | Compound for an organic electric element, an organic electric element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11787789-B2 | Compound for an organic electric element, an organic electric element using the same, and an electronic device thereof | PIEZO1, ORAI2, OCIAD1 | TP53 4134/4885RXFP1 3879/4885PDE10A 3916/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.